Tropical Weight Loss
Photo by Sarah Chai Pexels Logo Photo: Sarah Chai

Does Saxenda come generic?

No. There is currently no therapeutically equivalent version of Saxenda available in the United States. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Saxenda. These medications may be counterfeit and potentially unsafe.

drugs.com - Generic Saxenda Availability - Drugs.com
Where is excess fat stored in the body?
Where is excess fat stored in the body?

Most fat is stored underneath the skin and is known as subcutaneous fat. That is the fat that is visible and that you can feel. The rest of the fat...

Read More »
Last updated Apr 17, 2018
Will pannus go away with weight loss?
Will pannus go away with weight loss?

Surgical removal is the only way to get rid of the panniculus, which doesn't respond to diet or exercise. Although weight loss can help decrease...

Read More »
Last updated Nov 14, 2018

Last updated on Dec 7, 2022.

Saxenda is a brand name of liraglutide, approved by the FDA in the following formulation(s): No. There is currently no therapeutically equivalent version of Saxenda available in the United States. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Saxenda. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: Generic Drug FAQ.

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

Syringe device with a dose limiting mechanism and an additional safety mechanism

Patent 10,220,155

Issued: March 5, 2019

Assignee(s): Novo Nordisk A/S

A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose. Patent expiration dates: July 17, 2026

✓ Drug product

Patent 10220155*

Patent expiration dates: January 17, 2027

Patent 10,357,616

Patent expiration dates: January 20, 2026

✓ Drug product

Patent 10,376,652

Patent expiration dates: January 20, 2026

✓ Drug product

Patent 11,097,063

Patent expiration dates: July 17, 2026

✓ Drug product

Patent 11,311,679

Patent expiration dates: January 20, 2026

✓ Drug product

Patent 11,446,443

Patent expiration dates: October 20, 2025

✓ Drug product

Derivatives of GLP-1 analogs

Patent 6,268,343

Issued: July 31, 2001

Inventor(s): Knudsen; Liselotte Bjerre & Huusfeldt; Per Olaf & Nielsen; Per Franklin & Kaarsholm; Niels C. & Olsen; Helle Birk & Bj.o slashed.rn; S.o slashed.ren Erik & Pedersen; Freddy Zimmerdahl & Madsen; Kjeld

Assignee(s): Novo Nordisk A/S

The present invention relates to GLP-1 derivatives having a lipophilic substituent, pharmaceutical compositions comprising same, and methods of making an using same. The GLP-1 derivatives of the present invention have a protracted profile of action. Patent expiration dates: August 22, 2022 ✓ Patent use: METHOD FOR CHRONIC WEIGHT MANAGEMENT BY TREATING OBESITY ✓ Drug substance ✓ Drug product

February 22, 2023

✓ Pediatric exclusivity

Automatic injection device with reset feature

Patent 6,899,699

Issued: May 31, 2005

Inventor(s): Enggaard; Christian

Assignee(s): Novo Nordisk A/S

The present invention relates to a dose setting and expelling device comprising a drive member and a dose setting mechanism which simultaneously sets a given dose and stores the energy necessary for a subsequently driving the drive member in order to expel a dose of medicine from an injection device. According to the invention the dose setting mechanism allows adjustment in both directions, such that a given set dose can be reduced or cancelled by reversing the input motion, typically by rotating a setting member backwardly, this in contrast to the known devices which either requires an additional release mechanism or which cannot be reversed at all. Patent expiration dates: July 1, 2022

✓ Pediatric exclusivity

Needle mounting system and a method for mounting a needle assembly

Patent 7,762,994

Issued: July 27, 2010

Inventor(s): Klint; Henrik Sonderskov & Radmer; Jim & Smedegaard; Jorgen K & Nielsen; Jan Frank & Jensen; Peter Moller & Jensen; Jens Moller

Assignee(s): Novo Nordisk A/S

A needle mounting system and methods for mounting a needle assembly on a needle mount are disclosed. The needle mounting system includes a needle hub having protrusions extending radially inward. A needle mount has a plurality of slots to receive the protrusions. The slots have a first portion that defines a passageway substantially parallel to a longitudinal axis of the needle mount and a second portion substantially perpendicular to the axis. The needle hub and mount provide a method wherein a needle assembly may be mounted on an injection device without completely rotating the needle hub relative to the needle mount. Patent expiration dates: May 23, 2024

✓ Drug product

November 23, 2024

✓ Pediatric exclusivity

Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices

Patent 8,114,833

Issued: February 14, 2012

Inventor(s): Pedersen; Tina Bjeldskov & Bonde; Claude & Engelund; Dorthe Kot

Assignee(s): Novo Nordisk A/S

The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation. Patent expiration dates: August 13, 2025

✓ Drug product

February 13, 2026

✓ Pediatric exclusivity

Needle mounting system and a method for mounting a needle assembly

Patent 8,579,869

Issued: November 12, 2013

Assignee(s): Novo Nordisk A/S

A needle mounting system and methods for mounting a needle assembly on a needle mount are disclosed. The needle mounting system includes a needle hub having protrusions extending radially inward. A needle mount has a plurality of slots to receive the protrusions. The slots have a first portion that defines a passageway substantially parallel to a longitudinal axis of the needle mount and a second portion substantially perpendicular to the axis. The needle hub and mount provide a method wherein a needle assembly may be mounted on an injection device without completely rotating the needle hub relative to the needle mount. Patent expiration dates: June 30, 2023

✓ Drug product

Can you lose 100 pounds and not have excess skin?
Can you lose 100 pounds and not have excess skin?

However, with significant weight loss comes excess skin that does not bounce back. For some patients, even though they lose hundreds of pounds,...

Read More »
Last updated Oct 10, 2022
How do you trigger fat-burning process?
How do you trigger fat-burning process?

12 Ways to Promote Long-Term Fat Loss Start strength training. ... Follow a high protein diet. ... Get more sleep. ... Eat more healthy fats. ......

Read More »
Last updated Sep 16, 2019

Learn More »
Promotion

December 30, 2023

✓ Pediatric exclusivity

Automatic injection device with reset feature

Patent 8,672,898

Issued: March 18, 2014

Assignee(s): Novo Nordisk A/S

The present invention relates to a dose setting and expelling device comprising a drive member and a dose setting mechanism which simultaneously sets a given dose and stores the energy necessary for a subsequently driving the drive member in order to expel a dose of medicine from an injection device. According to the invention the dose setting mechanism allows adjustment in both directions, such that a given set dose can be reduced or cancelled by reversing the input motion, typically by rotating a setting member backwardly, this in contrast to the known devices which either requires an additional release mechanism or which cannot be reversed at all. Patent expiration dates: January 2, 2022

✓ Drug product

July 2, 2022

✓ Pediatric exclusivity

Injection device with torsion spring and rotatable display

Patent 8,684,969

Issued: April 1, 2014

Assignee(s): Novo Nordisk A/S

The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof. Patent expiration dates: October 20, 2025

✓ Drug product

April 20, 2026

✓ Pediatric exclusivity

Stable formulation of modified GLP-1

Patent 8,846,618

Issued: September 30, 2014

Assignee(s): Novo Nordisk A/S

Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof. Patent expiration dates: June 27, 2022

✓ Drug product

December 27, 2022

✓ Pediatric exclusivity

Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left

Patent 8,920,383

Issued: December 30, 2014

Assignee(s): Novo Nordisk A/S

A mechanism for preventing setting of a dose, which exceeds the amount of a medicament in a reservoir in an injection device. The device comprises a threaded piston rod, a limiter and a driver. The three elements are arranged such that during dose setting, the limiter is moved towards an end-of-contend position, wherein dose setting is limited. The invention comprises an accumulative and a non-accumulative embodiment. The invention further relates to a mechanism for prevention ejection of a dose exceeding the set dose. Patent expiration dates: July 17, 2026

✓ Drug product

January 17, 2027

✓ Pediatric exclusivity

Automatic injection device with a top release mechanism

Patent 9,108,002

Issued: August 18, 2015

Assignee(s): Novo Nordisk A/S

The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle. Patent expiration dates: January 26, 2026

✓ Drug product

July 26, 2026

✓ Pediatric exclusivity

Dial-down mechanism for wind-up pen

Patent 9,132,239

Issued: September 15, 2015

Assignee(s): Novo Nordisk A/S

The present invention relates to a dial-down mechanism for an injection device comprising a torsion spring for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising a ratchet arm (21) engaging a ring element (10) and a reset element (30) which acts on a knob located on the periphery of the ratchet arm (21) to move the ratchet arm (21) out of engagement with the ring element (10) in order to allow the set dose to be reduced. Patent expiration dates: February 1, 2032

✓ Drug product

August 1, 2032

✓ Pediatric exclusivity

Injection device with an end of dose feedback mechanism

Patent 9,457,154

Issued: October 4, 2016

Assignee(s): Novo Nordisk A/S

An injection device with a dose delivering mechanism being adapted to provide a non-visual, e.g. audible and/or tactile, feedback signal when a set dose has been at least substantially injected. A first and a second part of the injection device are adapted to perform a relative rotational movement with respect to each other. The relative rotational movement causes at least two parts of the injection device to abut or engage, and this abutment or engagement causes the non-visual feedback signal to be generated. A very distinct and precise feedback is provided as compared to prior art axial solutions because the generation of the feedback signal is initiated by the relative rotational movement. Feedback signal may be generated by a change in a rotational velocity of at least one part, e.g. by changing the pitch of a threaded portion or by engaging a non-rotating part and a rotating part, thereby causing the non-rotating part to start rotating. May alternatively be generated by building up and releasing a tension. The injection device is suitable for injecting insulin. Patent expiration dates: September 27, 2027

✓ Drug product

How can I shrink my appetite fast?
How can I shrink my appetite fast?

13 Science-Based Ways to Reduce Hunger and Appetite Eat enough protein. ... Opt for fiber-rich foods. ... Drink plenty of water. ... Choose solids...

Read More »
Last updated Jan 20, 2020
How can I slim my stomach in a week?
How can I slim my stomach in a week?

Additionally, check out these tips for how to burn belly fat in less than a week. Include aerobic exercises in your daily routine. ... Reduce...

Read More »
Last updated Nov 23, 2021

March 27, 2028

✓ Pediatric exclusivity

Automatic injection device with reset feature

Patent 9,486,588

Issued: November 8, 2016

Assignee(s): Novo Nordisk A/S

The present invention relates to a dose setting and expelling device comprising a drive member and a dose setting mechanism which simultaneously sets a given dose and stores the energy necessary for a subsequently driving the drive member in order to expel a dose of medicine from an injection device. According to the invention the dose setting mechanism allows adjustment in both directions, such that a given set dose can be reduced or cancelled by reversing the input motion, typically by rotating a setting member backwardly, this in contrast to the known devices which either requires an additional release mechanism or which cannot be reversed at all. Patent expiration dates: January 2, 2022

✓ Drug product

July 2, 2022

✓ Pediatric exclusivity

Automatic injection device with a top release mechanism

Patent 9,616,180

Issued: April 11, 2017

Assignee(s): Novo Nordisk A/S

The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle. Patent expiration dates: January 20, 2026

✓ Drug product

July 20, 2026

✓ Pediatric exclusivity

Injection device with torsion spring and rotatable display

Patent 9,687,611

Issued: June 27, 2017

Assignee(s): Novo Nordisk A/S

The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof. Patent expiration dates: February 27, 2027

✓ Drug product

August 27, 2027

✓ Pediatric exclusivity

Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left

Patent 9,775,953

Issued: October 3, 2017

Assignee(s): Novo Nordisk A/S

A mechanism for preventing setting of a dose, which exceeds the amount of a medicament in a reservoir in an injection device. The device can contain a threaded piston rod, a limiter and a driver. The three elements can be arranged such that during dose setting, the limiter is moved towards an end-of-content position, wherein dose setting is limited. The invention contains an accumulative and a non-accumulative embodiment. The invention further relates to a mechanism for preventing ejection of a dose exceeding the set dose. Patent expiration dates: July 17, 2026

✓ Drug product

January 17, 2027

✓ Pediatric exclusivity

Injection device with an end of dose feedback mechanism

Patent 9,861,757

Issued: January 9, 2018

Assignee(s): Novo Nordisk A/S

An injection device with a dose delivering mechanism being adapted to provide a non-visual, e.g. audible and/or tactile, feedback signal when a set dose has been at least substantially injected. A first and a second part of the injection device are adapted to perform a relative rotational movement with respect to each other. The relative rotational movement causes at least two parts of the injection device to abut or engage, and this abutment or engagement causes the non-visual feedback signal to be generated. A very distinct and precise feedback is provided as compared to prior art axial solutions because the generation of the feedback signal is initiated by the relative rotational movement. Feedback signal may be generated by a change in a rotational velocity of at least one part, e.g. by changing the pitch of a threaded portion or by engaging a non-rotating part and a rotating part, thereby causing the non-rotating part to start rotating. May alternatively be generated by building up and releasing a tension. The injection device is suitable for injecting insulin. Patent expiration dates: January 20, 2026

✓ Drug product

July 20, 2026

✓ Pediatric exclusivity

Liraglutide in cardiovascular conditions

Patent 9,968,659

Issued: May 15, 2018

Assignee(s): Novo Nordisk A/S

The present invention relates to the GLP-1 receptor agonist liraglutide for use in medicine. Patent expiration dates: January 9, 2037 ✓ Patent use: CARDIOVASCULAR OUTCOMES TRIAL OF LIRAGLUTIDE 1.8 MG IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE

July 9, 2037

✓ Pediatric exclusivity

drugs.com - Generic Saxenda Availability - Drugs.com
What hydrates better water or Gatorade?
What hydrates better water or Gatorade?

While Gatorade can help you stay hydrated, it's best to only drink it when needed. For people who aren't exercising for at least one hour, five...

Read More »
Last updated Feb 22, 2018
What's the boiled egg diet?
What's the boiled egg diet?

The boiled egg diet is a fad diet that promises fast weight loss. As the name implies, the diet involves eating several servings of hard-boiled...

Read More »
Last updated Oct 20, 2020
How can I slim my stomach naturally?
How can I slim my stomach naturally?

Here are 29 science-backed methods to help you lose extra belly fat. Cut calories, but not too much. ... Eat more fiber, especially soluble fiber....

Read More »
Last updated Apr 20, 2019

Learn More »
Promotion
Is B12 good for hair growth?
Is B12 good for hair growth?

One of those vital nutrients is B12, also known as cobalamin. B12 promotes healthy hair growth by assisting in the production of oxygen-rich red...

Read More »
Last updated Dec 26, 2020